These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35429496)

  • 1. Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.
    Al Jurdi A; Gassen RB; Borges TJ; Lape IT; Morena L; Efe O; Solhjou Z; El Fekih R; Deban C; Bohan B; Pattanayak V; Kotton CN; Azzi JR; Riella LV
    Kidney Int; 2022 Jun; 101(6):1282-1286. PubMed ID: 35429496
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.
    Benning L; Morath C; Bartenschlager M; Kim H; Reineke M; Beimler J; Buylaert M; Nusshag C; Kälble F; Reichel P; Töllner M; Schaier M; Klein K; Benes V; Rausch T; Rieger S; Stich M; Tönshoff B; Weidner N; Schnitzler P; Zeier M; Süsal C; Hien Tran T; Bartenschlager R; Speer C
    Am J Transplant; 2022 Jul; 22(7):1873-1883. PubMed ID: 35384272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients.
    Schimpf J; Davidovic T; Abbassi-Nik A; Sprenger-Mähr H; Lhotta K; Zitt E
    Transpl Int; 2022; 36():10357. PubMed ID: 35391899
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
    Haller MC; Kaiser RA; Langthaler S; Brandstetter C; Apfalter P; Kerschner H; Cejka D
    Transpl Int; 2021; 35():10026. PubMed ID: 35185359
    [No Abstract]   [Full Text] [Related]  

  • 6. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.
    Correia AL; Leal R; Pimenta AC; Fernandes M; Guedes Marques M; Rodrigues L; Santos L; Romãozinho C; Sá H; Pratas J; Araújo L; Figueiredo A; Alves R
    Clin Transplant; 2022 Apr; 36(4):e14585. PubMed ID: 34997797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients.
    Mungmunpuntipantip R; Wiwanitkit V
    Exp Clin Transplant; 2022 Nov; 20(11):1048. PubMed ID: 36524892
    [No Abstract]   [Full Text] [Related]  

  • 8. Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients.
    Grupper A; Rabinowich L; Ben-Yehoyada M; Katchman E; Baruch R; Freund T; Hagin D; Shlomo SB; Schwartz D; Schwartz IF; Shashar M; Bassat OK; Halperin T; Turner D; Saiag E; Goykhman Y; Shibolet O; Levy S; Houri I; Katchman H
    Transplant Proc; 2022; 54(6):1439-1445. PubMed ID: 35346486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients.
    Masset C; Benotmane I; Dantal J; Garandeau C; Gauthier-Vargas G; Cantarovich D; Meurette A; Giral M; Caillard S; Blancho G
    Kidney Int; 2022 Apr; 101(4):825-826. PubMed ID: 35167873
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.
    Qin CX; Auerbach SR; Charnaya O; Danziger-Isakov LA; Ebel NH; Feldman AG; Hsu EK; McAteer J; Mohammad S; Perito ER; Thomas AM; Chiang TPY; Garonzik-Wang JM; Segev DL; Mogul DB
    Am J Transplant; 2022 Oct; 22(10):2481-2483. PubMed ID: 35510786
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody Responses Against Emerging SARS-CoV-2 Omicron Lineages After the Fourth Dose of mRNA Vaccine in Kidney Transplant Recipients.
    Al Jurdi A; Gassen RB; Borges TJ; Lape IT; Morena L; Hullekes F; Efe O; Kotton CN; Riella LV
    Transplantation; 2023 Jun; 107(6):e178-e181. PubMed ID: 36978222
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.
    Matsunami M; Suzuki T; Yashima J; Kuji H; Matsue K
    Clin Exp Nephrol; 2023 Jan; 27(1):98-99. PubMed ID: 35931918
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.
    Furukawa K; Tjan LH; Kurahashi Y; Sutandhio S; Nishimura M; Arii J; Mori Y
    JAMA Netw Open; 2022 May; 5(5):e2210780. PubMed ID: 35532938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients.
    Bertrand D; Lemée V; Laurent C; Lemoine M; Hanoy M; Le Roy F; Nezam D; Pruteanu D; Lebourg L; Grange S; Plantier JC; Boyer O; Guerrot D; Candon S
    Am J Transplant; 2022 May; 22(5):1498-1500. PubMed ID: 35007383
    [No Abstract]   [Full Text] [Related]  

  • 15. A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients.
    Benotmane I; Bruel T; Planas D; Fafi-Kremer S; Schwartz O; Caillard S
    Kidney Int; 2022 May; 101(5):1073-1076. PubMed ID: 35231463
    [No Abstract]   [Full Text] [Related]  

  • 16. Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.
    Cao J; Liu X; Muthukumar A; Gagan J; Jones P; Zu Y
    Clin Chem; 2021 Dec; 68(1):251-253. PubMed ID: 34358295
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
    Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
    Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study.
    Yahav D; Rahamimov R; Mashraki T; Ben-Dor N; Steinmetz T; Agur T; Zingerman B; Herman-Edelstein M; Lichtenberg S; Ben-Zvi H; Bar-Haim E; Cohen H; Rotem S; Elia U; Margalit I; Zvi BR
    Transpl Int; 2022; 35():10204. PubMed ID: 35529596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients.
    Hamaya T; Hatakeyama S; Yoneyama T; Tobisawa Y; Kodama H; Fujita T; Murakami R; Fujita N; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Saitoh H; Narumi S; Tomita H; Ohyama C
    Sci Rep; 2022 Apr; 12(1):5876. PubMed ID: 35393481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Correlation Between Responders and Non-Responders to the Second Coronavirus Disease Vaccination In Kidney Transplant Recipients: A Retrospective Single-Center Cohort Study.
    Matsunami M; Suzuki T; Sugihara S; Toishi T; Nagaoka K; Fukuda J; Ohara M; Takanashi Y; Ochi A; Yashima J; Kuji H; Matsue K
    Transplant Proc; 2022; 54(6):1483-1488. PubMed ID: 35868872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.